We recently described a case of a Thrombospondin Type-1 Domain containing 7A (THSD7A) associated membranous nephropathy in a female patient who was synchronously suffering from a THSD7A-positive malignancy. We here investigated the role of THSD7A as a new potential tumor antigen by evaluating over 20 000 tissue spots in more than 70 different tumor entities by immunohistochemistry using tissue microarrays. THSD7A expression was highly variable in different neoplasias with differing staining patterns. Both gain and loss of THSD7A expression compared to expression status in non-tumor tissue were linked to tumor-specific markers in the different tumor entities and were of prognostic value. The potential role of THSD7A in tumor development and therapy needs further investigation.

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22440DOI Listing

Publication Analysis

Top Keywords

thsd7a expression
12
role thsd7a
8
tumor entities
8
thsd7a
6
expression human
4
human cancer
4
cancer described
4
described case
4
case thrombospondin
4
thrombospondin type-1
4

Similar Publications

Article Synopsis
  • Membranous nephropathy (MN) is an autoimmune kidney disease primarily caused by antibodies against PLA2R1, leading to nephrotic syndrome and potential kidney failure.
  • Researchers are using various animal models, including the previously established Heymann nephritis rat and C-BSA models, to study MN, though these models have limitations due to their inability to express relevant target antigens.
  • Newer antigen-specific models have been developed to better reflect the disease's characteristics and progression, and this review examines the pros and cons of existing models to guide future research in MN.
View Article and Find Full Text PDF

Multi-scalar data integration decoding risk genes for chronic kidney disease.

BMC Nephrol

October 2024

Programme in Cardiovascular and Metabolic Disorders (CVMD) and Centre for Computational Biology (CCB), Duke-NUS Medical School, 8 College Road, Singapore, Singapore.

Background: Chronic Kidney Disease (CKD) impacts over 10% of the global population, and recent advancements in high-throughput analytical technologies are uncovering the complex physiology underlying this condition. By integrating Genome-Wide Association Studies (GWAS), RNA sequencing (RNA-seq/RNA array), and single-cell RNA sequencing (scRNA-seq) data, our study aimed to explore the genes and cell types relevant to CKD traits.

Methods: GWAS summary data for end-stage renal failure (ESRD) and decreased eGFR (CKD) with or without diabetes and (micro)proteinuria were obtained from the GWAS Catalog and the UK Biobank (UKB) database.

View Article and Find Full Text PDF

The most characteristic feature of membranous nephropathy (MN) is the presence of subepithelial electron dense deposits and the consequential thickening of the glomerular basement membrane. There have been great advances in the understanding of the destiny of immune complexes in MN by the benefit of experimental models represented by Heymann nephritis. Subepithelial immune complexes are formed by autoantibodies targeting native autoantigens or exogenous planted antigens such as the phospholipase A2 receptor (PLA2R) and cationic BSA respectively.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to understand brain aging by developing a cortical epigenetic clock and conducting a genome-wide association study (GWAS) involving brain tissue from nearly 700 participants postmortem, as part of the Rush Memory and Aging Project and the Religious Orders Study.
  • - Researchers identified the strongest genetic association with brain aging at SNP rs4244620, which also showed significant ties to cognitive decline and neurodegenerative signs, using additional data from nearly 1,700 subjects.
  • - The findings highlighted specific proteins, like TMEM106B and THSD7A, that correlate with Alzheimer’s disease pathology and cognitive decline, reinforcing their potential roles in the mechanisms of brain aging.
View Article and Find Full Text PDF

Membranous nephropathy (MN) continues to be a leading cause of nephrotic syndrome in non-diabetic adults. As a unique subtype in the serology-based classification of MN, thrombospondin type 1 domain containing 7A (THSD7A)-associated MN has attracted increasing interest, because, unlike other autoantigens, THSD7A is also expressed in preclinical species, facilitating the study of its role in MN. A heterologous mouse model of THSD7A-associated MN was previously established using a proprietary in-house antibody that was unfortunately not available to the research community.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!